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Background. DNA helicases are ubiquitous enzymes that unwind DNA in an ATP-dependent and directionally specific manner.
Unwinding of double-stranded DNA is essential for the processes of DNA repair, recombination, transcription, and DNA
replication. Five human DNA helicases sharing sequence similarity with the E. coli RecQ helicase have been identified. Three of
the human RecQ helicases are implicated in hereditary diseases (Bloom syndrome, Werner syndrome, and Rothmund-Thomson
syndrome) which display clinical symptoms of premature aging and cancer. RECQ1 helicase is the most highly expressed of the
human RecQ helicases; however, a genetic disease has yet not been linked to mutations in the RECQ1 gene, and the biological
functions of human RECQ1 in cellular DNA metabolism are not known. Methodology/Principal Findings. In this study, we
report that RECQ1 becomes phosphorylated upon DNA damage and forms irradiation-induced nuclear foci that associate with
chromatin in human cells. Depletion of RECQ1 renders human cells sensitive to DNA damage induced by ionizing radiation or
the topoisomerase inhibitor camptothecin, and results in spontaneous c-H2AX foci and elevated sister chromatid exchanges,
indicating aberrant repair of DNA breaks. Consistent with a role in homologous recombinational repair, endogenous RECQ1 is
associated with the strand exchange protein Rad51 and the two proteins directly interact with high affinity. Conclusion/
Significance. Collectively, these results provide the first evidence for a role of human RECQ1 in the response to DNA damage
and chromosomal stability maintenance and point to the vital importance of RECQ1 in genome homeostasis.
Citation: Sharma S, Brosh RM (2007) Human RECQ1 Is a DNA Damage Responsive Protein Required for Genotoxic Stress Resistance and Suppression
of Sister Chromatid Exchanges. PLoS ONE 2(12): e1297. doi:10.1371/journal.pone.0001297
INTRODUCTION
It is believed that RecQ helicases have multiple roles in three
facets of DNA metabolism (repair, replication and recombination),
S-phase checkpoint, and telomere maintenance; consequently,
they are considered caretakers of the genome [1,2]. Three of the
five human RecQ genes, designated BLM, WRN and RECQ4, have
been genetically linked to the autosomal recessive diseases Bloom
Syndrome (BS), Werner Syndrome (WS) and Rothmund-Thom-
son Syndrome (RTS), respectively. All three of these rare human
diseases are characterized by a predisposition to cancer and
chromosome instability, but the clinical features and cellular
phenotypes are different from each other, suggesting unique roles
of BLM, WRN, and RECQ4 helicases as tumor suppressors.
The biological significance of the remaining two human RecQ
helicases, RECQ1 and RECQ5, is not yet known. The RECQ1
(RECQL) gene, originally cloned independently by two groups
[3,4], is located on chromosome 12p11-12 and encodes a 649
amino acid protein with a molecular mass of 73 kDa. RECQ1 was
found to be the most abundant of the five human RecQ helicases
in resting B cells, and its expression is upregulated in response to
EBV transformation or treatment with the tumor promoting agent
phorbol myristic acetate [5]. Despite the fact that RECQ1 was the
first human RecQ helicase protein to be identified, little is known
about its genetic functions in mammalian cells. Studies utilizing
chicken DT40 cells have shown that RECQ1 and RECQ5 have
roles in cell viability under a BLM-impaired condition, indicating
a backup function for these helicases [6]. However, BLM,
RECQ5, and RECQL have nonredundant roles in suppressing
crossovers in mouse embryonic stem cells and fibroblasts [7,8],
suggesting a cell type or species-specific difference between the
chicken and mouse systems.
In order to better understand and appreciate the molecular-
genetic functions of RECQ1, its biochemical properties and
protein interactions have been studied. RECQ1 is a nonprocessive
helicase that unwinds dsDNA with a 39 to 59 polarity [9]. RECQ1
preferentially unwinds forked duplex substrates and two homol-
ogous recombination (HR) intermediates, the four-stranded
Holliday Junction and three-stranded D-loop [10]. In addition
to its helicase activity, RECQ1 efficiently catalyzes strand
annealing of complementary ssDNA molecules in a reaction that
is modulated by nucleotide binding to RECQ1 [10]. It was
recently shown that RECQ1 assumes different oligomeric forms to
perform its helicase and strand annealing activities [11]. The
human single-stranded DNA binding protein Replication Protein
A (RPA) modulates RECQ1 catalytic activities. By binding to
ssDNA, RPA inhibits RECQ1 strand annealing [10]. In contrast,
RPA stimulates RECQ1 unwinding activity in a specific manner
which is likely mediated by a physical interaction with the RPA70
subunit [12]. RECQ1 binds to human mismatch repair factors
(MSH2-MSH6, MLH1-PMS2, EXO-1) [13]. A functional
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the abilities of RECQ1 to stimulate the endo- and exo-nucleolytic
incision activities of EXO-1 and MSH2-MSH6 to enhance
RECQ1 helicase activity [13]. RECQ1 was also reported to be
associated with the Type IA Topoisomerase IIIa (Topo IIIa)i n
human cells [14]. Although the catalytic activities and protein
interactions of RECQ1 suggest its involvement in the regulation of
genetic recombination at some level, the precise roles of RECQ1
in cellular DNA metabolism are not understood.
In this study, we have investigated the potential importance of
human RECQ1 in the DNA damage response and maintenance
of chromosomal stability. In response to ionizing radiation (IR)-
induced DNA damage, RECQ1 helicase undergoes sub-nuclear
redistribution, protein phosphorylation, and preferential associa-
tion with chromatin. RECQ1 depletion by RNA interference
resulted in reduced cell proliferation, compromised cellular
resistance to IR or camptothecin (CPT), and elevated sister
chromatid exchange (SCE) in cells either untreated or exposed to
CPT, suggesting that RECQ1 is important for the repair of
endogenous or exogenously induced DNA damage.
MATERIALS AND METHODS
Recombinant proteins
Recombinant human RECQ1 helicase was overexpressed in insect
cells using a baculovirus encoding recombinant RECQ1 kindly
provided by Dr. Alessandro Vindigni (International Center for
Genetic Engineering and Biotechnology, Trieste, Italy) and
purified as previously described [10]. Rad51 was generously
provided by Dr. Ian Hickson (Cancer Research UK Laboratories).
Cell lines and culture conditions
Human HeLa and U2OS cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (GIBCO-BRL, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (Hyclone Laboratories,
Logan, UT), 100 U/ml penicillin and 100 mg/ml streptomycin
(Life Technologies, Carlsbad, CA). Cells were grown in a
humidified 5% CO2 incubator at 37uC.
RECQ1 silencing in HeLa cells
For siRNA mediated silencing of RECQ1, the siRNA duplexes were
19 base pairs with a 2-base overhang (Dharmacon Research,
Chicago, IL). Thesequences(sense strand)of RECQ1siRNAL1and
siRNAL2 oligonucleotides are GCAAGGAGAUUUACUCGAA-
UU and GAAGAUUAUUGCACACUUUUU, respectively. The
control siRNA has the sequence UAGCGACUAAACACAUCAA-
UU. Cells were transfected with siRNA duplexes by using Oligo-
fectamine (Invitrogen, Carlsbad, CA) following the manufacturer’s
instructions. For constitutive silencing of RECQ1 expression in
HeLa cells, two expression vectors containing short hairpin RNA
(shRNA) sequences directed against RECQ1 (Origene, Rockville,
MD) and a puromycin-resistance gene were transfected into HeLa
cells using Fugene6 (Roche, Mannheim, Germany) according to the
manufacturer’s protocol. A control shRNA vector which has no
homologytoanyhumansequencewasusedasacontrol.3-dayspost-
transfection, cells were maintained in DMEM growth medium
containing 10% serum and 0.5 mg/ml puromycin. Two sets of
clones, each expressing one of the two shRNAs directed against
RECQ1, were then used for further experiments.
Cell proliferation analyses
Cells (24 h after transfection with either the control or two
different RECQ1 siRNAs) were seeded in quadruplicate at a
density of 300 cells/well in 96-well plates and allowed to adhere
for 16 h. Cell proliferation using CyQuant (Molecular Probes,
Eugene, OR) was assayed at 24, 48, 72, 96 and 120 h after
transfection. As an indication of cell growth, total DNA was
quantified at selected time points using a Fluorstar plate reader
(B&L Systems, Maarssen, Netherlands) from a standard curve
performed for each assay according to the manufacturer’s
instructions [15,16]. The effects of RECQ1-siRNA on cell viability
or growth were further determined by 3-(4, 5-Dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay.
48 h after siRNA transfection, cells were plated onto 96-well
plates at a density of 5610
3 per well and incubated for 16 h. The
medium was replaced with 100 ml of MTT solution and incubated
for 1 h. After incubation, the MTT solution was removed and cells
were suspended in 100% ethanol. Absorbance was measured at
590 nm using a microplate reader (Bio-Rad Laboratories,
Hercules, CA). For the quantitative determination of DNA
synthesis rate, mitogenic activity was determined by measuring
BrdU incorporation using BrdU Cell Proliferation ELISA (Roche
Diagnostics, Indianapolis, IN). Briefly, 48 h after siRNA transfec-
tion, 5610
3 cells were seeded in quadruplicates in 96-well plates
and allowed to adhere for 16 h. Cells were then labeled for 3 h
with bromodeoxyuridine, and DNA synthesis was measured with
the ELISA BrdUrd assay according to the manufacturer’s
instructions. The absorbance values correlate directly to the
amount of DNA synthesis and the number of proliferating cells in
culture. Absorbance was measured at 450 nm with a microplate
reader (Bio-Rad Laboratories, Hercules, CA). All cell proliferation
assays were performed at least four times.
Clonogenic and survival assays of shRNA-treated
cells
To analyze the relative growth rate of the shRNA treated cells,
5610
3 cells were seeded in a 24-well plate in triplicate and the
total cell number was counted at indicated time points using a
Coulter counter (Beckman, Fullerton, CA). For the clonogenic
assays, 500 cells were reseeded in 6-well plates. The number and
size of methylene blue-stained colonies were recorded after 5–
9 days of growth in complete medium.
Cell cycle analysis
HeLa cells were harvested by trypsinization 72 h after transfection
and fixed with 70% ethanol. After RNase treatment, cells were
stained with propidium iodide, and DNA histograms were acquired
using a FACScalibur. Cell cycle distributions were modeled using
Multicycle (Phoenix Flow Systems, San Diego, CA).
Analysis of cellular apoptosis
To assay the endogenous spontaneous cellular apoptosis, cells were
treated with either the control or RECQ1 siRNA duplexes for
48 h. Subsequently, the cytoplasmic histone-associated DNA
fragments, which are indicative of ongoing apoptosis, were
quantitatively measured by using the Cell Death Detection
ELISAPLUS photometric enzyme-immunoassay method (Roche
Applied Science, Indianapolis, IN) according to the manufactur-
er’s instructions. To assay cell sensitization and the extent of
apoptosis induction after DNA damage or oxidative stress, an
equal number of siRNA-treated cells were subcultured in complete
medium containing 400 mMH 2O2 for 3 h followed by a recovery
period in complete medium for 21 h. Apoptosis induction was
then quantified by using the ELISAPLUS death assay. Western
detection of PARP-1 cleavage was performed using monoclonal
mouse anti-PARP-1 antibody (2 mg/ml; BD Biosciences PharMin-
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PARP-1.
DNA damage survival assays
Survival assays utilizing siRNA transfected HeLa cells were
performed 48 h after the transfection. Cells (transfected with
either the control or two different RECQ1 siRNAs) were seeded in
quadruplicate at a density of 300 cells/well in 96-well plates,
allowed to adhere for 14–16 h, and subsequently exposed to
increasing doses of IR using Gammacell 40 (Nordion Internation-
al, Inc.), a
137Cs source emitting at a fixed dose rate of 0.82 Gy/
min. To determine CPT sensitivity, cells were exposed continu-
ously to increasing concentrations of CPT (Sigma, St. Louis, MO).
Following treatment, cells were allowed to grow at 37uC for 5 days
in 5% CO2. Plates were frozen at 280uC. Total DNA was
quantified using CyQuant (Molecular Probes, Eugene, OR) and
compared with untreated controls as an indication of cell growth
as described [15,16]. Quantification of DNA using CyQuant was
performed using a Fluorstar plate reader (B&L Systems) according
to the manufacturer’s instructions.
Radioresistant DNA synthesis and G2/M checkpoint
assays
Cells transfected with control or RECQ1 siRNA were used for
radioresistant DNA synthesis assays 48 h after transfection. Cells
were labeled for 24 h with 10 nCi/ml [
14C]thymidine and then
incubated for another 24 h in non-radioactive medium. Thirty
min after irradiation (10 Gy), 2.5 mCi/ml [
3H]thymidine was
added to the medium for 15 min to allow cell labeling. The cells
were collected and transferred to Whatman filters and fixed
sequentially with 70% methanol followed by 95% methanol.
Radioactivity was measured in a liquid scintillation counter. The
measure of DNA synthesis was derived from resulting ratios of
[
3H]/[
14C] and expressed as a percentage of control values. For
G2/M checkpoint assays, HeLa cells were transfected with siRNAs
and irradiated 48 h after transfection. Cells were harvested 1 h
after irradiation, ethanol-fixed, stained with propidium iodide and
anti-phosphohistone H3 antibodies followed by Alexa Fluor 488-
conjugated secondary antibody (Molecular Probes, Carlsbad, CA),
and analyzed using a FACScalibur.
Sister chromatid exchange assays
SCEs were detected as described [17]. At 36 h after HeLa cells
were transfected with siRNA oligos, cultures were grown in the
presence of 100 mM of 5-bromodeoxyuridine (BrdU; Sigma)
through two cell cycles to achieve preferential labeling of sister
chromatids. Colcemid (Sigma) was added at a final concentration
of 0.05 mg/ml to accumulate mitotic cells 2 h prior to harvesting
cells. Harvested cells were then incubated in hypotonic solution
(0.06 M KCl) for 15 min at room temperature, and then fixed
with 3:1 (vol/vol) methanol–glacial acetic acid. Fixed cell
suspension was dropped onto a glass slide and air-dried. Slides
were aged for 3 days and stained with 5 mg/ml Hoechst 33258
(Sigma) for 10 min. Sister chromatid differentiation was per-
formed by the fluorescence-plus-Giemsa technique [17]. For
Mitomycin C (MMC) treatment, MMC was added to the culture
at a final concentration of 60 nM for 16 h prior to harvesting. For
CPT treatment, cells were exposed to 1 mM CPT for 1 h, washed
twice, and recovered in drug-free media containing BrdU for two
cell cycles before harvesting. Digitally captured images of at least
25 differentially stained metaphase chromosome spreads per
treatment were scored in a blinded fashion.
In situ fractionation and immunofluorescence
detection of endogenous RECQ1
HeLa cells grown on glass coverslips in 35-mm dishes to about
70% confluence were untreated or treated with IR (10 Gy). Six h
after IR treatment, the cells were processed for immunofluorescent
staining. For detection of chromatin bound protein, the in situ cell
fractionation procedure was performed before fixation [18].
Briefly, coverslips were washed in phosphate-buffered saline
(PBS), incubated in cytoskeleton buffer (10 mM PIPES (pH 6.8),
100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA,
0.5% Triton X-100) for 5 min on ice, followed by incubation in
cytoskeleton stripping buffer (10 mM Tris-HCl (pH 7.4), 10 mM
NaCl, 3 mM MgCl2, 1% Nonidet P-40, 0.5% sodium deoxycho-
late) for 5 min on ice. After several washes with ice-cold PBS, the
cells were fixed with 3.7% paraformaldehyde for 10 min and
permeabilized in 0.5% Triton X-100 solution for 10 min at room
temperature. Intact cells (not extracted with Nonidet P-40) were
fixed as described above. Cells were blocked with 10% FCS in
PBS and incubated with rabbit polyclonal anti-RECQ1 antibody
(1:1000, Santa Cruz Biotech, Santa Cruz, CA) overnight at 4uCi n
a humid chamber. Following five washes with 0.1% Triton X-100
in 1X PBS, cells were incubated with rhodamine conjugated goat
anti-rabbit IgG (1:500, Vector Laboratories, Burlingame, CA) for
1 h at 37uC. All antibodies were diluted in 5% FCS–PBS. After
washing five times, coverslips were mounted with Vectashield
mounting medium containing DAPI (Vector Laboratories) and
analyzed by fluorescence microscopy. Images were captured on an
AxioVision 3.1 microscope (Zeiss) with deconvolution using a
black and white CCD camera. Representative photographs from
three independent experiments are shown in the figures.
Biochemical fractionation
U2OS cells that were either untreated or exposed to IR (10 Gy) and
allowed to recover for 6 h were trypsinized and collected by
centrifugation. Cells were washed once with cold PBS and portioned
equally in four eppendorf tubes, and their sub-cellular fractionation
was performed as described [19]. Briefly, following centrifugation at
4uCf o r3m i na t3 0 0g, one pellet which represented the whole cell
pellet (P1) was frozen in liquid nitrogen and the remaining pellets
were resuspended in cold buffer A (10 mM PIPES (pH 7.0),
1 0 0m MN a C l ,3m MM g C l 2, 1 mM EGTA, 300 mM sucrose,
0.5 mM Na3VO4,5 0m MN a F ,1 0mg/ml aprotinin, 10 mg/ml
leupeptin, 10 mg/ml pepstatin A, and 1 mM phenylmethylsulfonyl-
fluoride (PMSF)) containing 0.5% Triton X-100 and incubated at
room temperature for 2 min to permeabilize cells. Following
centrifugation at 4uC for 3 min at 300 g, the supernatant which
represented cytosol and nucleosol fractions (S2) was collected and
frozen. The pellet was washed with cold buffer A. One pellet which
represented detergent-insoluble nuclei (P2) was frozen. The
detergent insoluble nuclei from the other pellet were then digested
with RNase-free DNase I (200 U/ml, New England Bio-Labs,
Ipswich, MA) in buffer A for 30 min at room temperature followed
by centrifugation at 4uC for 3 min at 300 g. The supernatant (S3)
was frozen, and the pellet that had been washed with cold buffer A
was either frozen (P3) or extracted with cold buffer A containing
0.25 M ammonium sulfate for 5 min at room temperature to
solubilize the remaining chromatin. The residual pellet which
represented the nuclear matrix fraction (P4) was collected by
centrifugationat4uCfo r3mi nat1 87 7g, and the supernatant which
contained chromatin (S4), as identified by the presence of histones,
was frozen. The pellet was frozen following a single wash with cold
buffer A and centrifugation at 800 g for 3 min. Proteins from
equivalent cell volumes of each fraction step were resolved by 10%
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Santa Cruz, CA), histone H4 (chromatin marker, 1:5000, Upstate
Biotech, Upstate, NY), and lamin B (nuclear matrix marker, 1:1000,
Abcam, Cambridge, MA) by immunoblotting.
RECQ1 immunoprecipitation and phosphatase
treatment
Whole cell extracts were prepared in lysis buffer (50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, and 1% (v/v) Triton X-100) supple-
mented with protease inhibitors (1 mg/ml leupeptin and pepstatin,
2 mg/ml aprotinin, and 1 mM PMSF) and phosphatase inhibitors
(1 mM Na3VO4 and 10 mM NaF). Using a polyclonal antibody
against human RECQ1 (Santa Cruz Biotech), immunoprecipita-
tion (IP) was performed essentially as previously described [13].
Each RECQ1 IP (normalized to contain 0.25 mg of protein as the
input) was washed twice in lambda phosphatase buffer (New
England BioLabs) and resuspended in 50 ml of lambda phospha-
tase buffer either in the presence or absence of lambda
phosphatase (500 U, New England BioLabs), followed by
incubation at 30uC for 1 h. Proteins were resolved by 12%
SDS-PAGE and immunoblotted for RECQ1 using rabbit
polyclonal RECQ1 antibody (1:750, Santa Cruz Biotech). For
the detection of phosphorylated RECQ1 in soluble and chroma-
tin-bound fractions, total soluble and chromatin-bound fractions
were prepared from aliquots of 1610
7 cells and analyzed by
immunoprecipitation and Western as described above.
ELISA
Wells were coated with 50 ml (1 ng/ml) of either BSA or RECQ1
protein diluted in carbonate buffer (0.016 M Na2CO3, 0.034 M
NaHCO3 (pH 9.6)), and incubated at 4uC overnight. The samples
were aspirated, and the wells were blocked for 2 h at 30uC with
blocking buffer (PBS, 0.5% Tween-20, 3% BSA). The wells were
washed with PBS containing 0.5% Tween-20. Serial dilutions of
Rad51 in blocking buffer were then added to the appropriate wells
of the ELISA plate and incubated for 1 h at 30uC. DNaseI
(100 U/ml) or ethidium bromide (EtBr) (50 mg/ml) was included
in the incubation with Rad51 in the binding step in the
corresponding wells to test for DNA mediated protein interaction.
The samples were aspirated, and the wells were washed five times
with washing buffer before addition of rabbit anti-Rad51 antibody
(Calbiochem, San Diego, CA) diluted 1:500 in blocking buffer and
incubated at 30uC for 1 h. Following three washes with washing
buffer, HRP-conjugated anti-rabbit secondary antibody diluted
1:10,000 in blocking buffer was added to the wells, and the
samples were incubated for 30 min at 30uC. After washing five
times, any Rad51 bound to the RECQ1 was detected using OPD
substrate (Sigma). The reaction was terminated after 3 min with 3
NH 2SO4 and absorbance readings were taken at 490 nm.
Co-immunoprecipitation experiments
Nuclear extracts were prepared from exponentially growing HeLa
cells as described previously [20]. Nuclear extract (1 mg of total
protein) was incubated with either rabbit polyclonal anti-RECQ1
(2 mg, Santa Cruz Biotech) or mouse monoclonal anti-Rad51
antibodies (2 mg, Oncogene) in buffer D (50 mM HEPES (pH 7.5),
100 mM KCl, 10% glycerol) for 4 h at 4uC. The mixture was
subsequently tumbled with 20 ml of protein G-agarose (Roche
Applied Science) at 4uC overnight. The beads were then washed
three times with buffer D supplemented with 0.1% Tween 20.
Proteins were eluted by boiling in SDS sample buffer, and half of the
eluate was resolved on 10% polyacrylamide Tris-glycine SDS gels,
and transferred to polyvinylidene difluoride membranes (Amersham
Biosciences,Piscataway,NJ).Themembraneswere blockedwith 5%
nonfat dry milk in PBS containing 0.1% Tween 20, and probed for
RECQ1 and Rad51 using anti-rabbit RECQ1 (1:750, Santa Cruz
Biotech) and anti-rabbit Rad51 (1:1000, Calbiochem) antibodies
respectively, followed by detection with a goat-anti-rabbit IgG
secondary antibody conjugated to horseradish peroxidase (HRP)
(Santa Cruz Biotechnology). RECQ1 and Rad51 on immunoblots
were detected using ECL Plus (Amersham Biosciences).
RESULTS
Of the five human RecQ helicases, RECQ1 is one of the least well
characterized intermsof its biologicalroles.Although RECQ1 isnot
implicatedasof yet ina human disease,studies of cells fromRECQL
knockout mice suggested a role of RECQ1 in the maintenance of
chromosomal stability and the repair of double strand breaks [8].
Other human RecQ helicases, particularly WRN and BLM, have
been proposed to participate in pathways which help cells to deal
with replicational stress or repair DNA damage [2]. Thus, we set out
to characterize the importance of human RECQ1 in the DNA
damageresponseinordertoobtainanunderstandingofitsbiological
relevance in cellular DNA metabolism.
DNA damage induced relocalization of nucleolar
RECQ1 helicase
First, we examined by immunofluorescence the sub-cellular
distribution of endogenous RECQ1 in human cells either untreated
or exposed to IR which directly introduces DNA strand breaks. In
untreated HeLa cells, RECQ1 displayed nuclear staining with a
predominant localization in nucleoli (Fig. 1A). Nucleolar localization
of RECQ1 in untreated cells was confirmed by co-staining with
nucleolin (Fig. 1A), consistent with its identification in the nucleolar
proteome [21,22]. Cellular exposure to IR (10 Gy) resulted in the
loss of RECQ1 nucleolar staining and the appearance of RECQ1
staining in the nucleoplasm (Fig. 1B). Approximately 70–80% of the
cells showed exclusion of RECQ1 from the nucleolus to the nuclear
compartment within 6 h after IR exposure.
Since the more well characterized BLM helicase has been
implicated in the cellular response to replicative stress [23–26], we
next assessed if relocalization of RECQ1 may also be elicited by
cellular exposure to the replication inhibitor hydroxyurea. The
sub-nuclear distribution of RECQ1 is altered upon hydroxyurea
treatment (Fig. S1A), suggesting that RECQ1 relocalization may
be a general response to DNA damage or replicational stress.
RECQ1 associates with chromatin upon IR exposure
We next sought to determine if endogenous RECQ1 would be
associated with damaged DNA. In situ fractionation based on
successive detergent extractions displayed punctuate pattern of
nuclear retention of the DNA bound RECQ1 upon IR exposure
(Fig. 1B). In order to determine the retention of RECQ1 at the sites
of double strand breaks, we looked for the co-localization of RECQ1
with c-H2AX and found only a small fraction of extraction-resistant
RECQ1 aggregates co-localized with c-H2AX foci (Fig. 1B).
Nuclear proteins from U2OS cells either untreated or harvested
6 h following IR (10 Gy) exposure were fractionated into soluble
nuclear, chromatin, or nuclear matrix components (Fig. 1C), and
fractions were immunoblotted for RECQ1 (Fig. 1D). RECQ1 pro-
tein fractionated with soluble nuclear proteins (Fig. 1D, S2 fraction)
from the untreated cells, with only a very minor fraction associated
with chromatin (Fig. 1D, S4 fraction). Following IR treatment,
RECQ1 was also found in the insoluble fractions (Fig. 1D), and a
significantly greater amount of RECQ1 fractionated with chromatin
that also contained histones (Fig. 1D, S4 fraction). RECQ1 was not
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contains lamin B (Fig. 1D). These results indicate that c-irradiation of
human cells targets RECQ1 to associate with chromatin.
Endogenous RECQ1 is phosphorylated in response
to DNA damage
A critical element of the DNA damage response is the activation of
signaling pathways by protein phosphorylation to initiate repair by
HR [27,28]. To assess if RECQ1 might be post-translationally
modified after DNA damage, RECQ1 was immunoprecipitated
from protein extracts prepared from cells that were either untreated
or c -irradiated (10 Gy) and harvested 6 h following exposure.
Western blot using anti-RECQ1 antibody demonstrated two
differentially migrating bands of RECQ1 in cell extracts with the
intensity of the slower migrating band much stronger in the
immunoprecipitates from the IR treated cells (Fig. 2A, lanes 1, 2).
Treatment of immunoprecipitated RECQ1 with lambda protein
phosphatase resulted in disappearance of the slower migrating band
(Fig. 2A, lanes 3, 4). Lambda phosphatase treatment of the RECQ1
immunoprecipitates in the presence of phosphatase inhibitors did
not affectthemobilityofthe slowermigrating band (data notshown).
These results indicate that the RECQ1 mobility shift observed in
response to IR was due to protein phosphorylation. This IR-induced
phosphorylation of RECQ1 was found to be both dependent on
irradiation dose and time (Fig. 2B, 2C). The slower migrating band
corresponding to phosphorylated RECQ1 was detected in immu-
noprecipitates from cells irradiated with a low IR dose of 2 Gy
(Fig. 2B), and maximal phosphorylation of endogenous RECQ1 was
obtained in 6 h after 10 Gy irradiation (Fig. 2C). RECQ1
immunoprecipitatesfrom the soluble (S2)andinsoluble (S4)fractions
from cells either untreated or c-irradiated (10 Gy, 6 h following
exposure) demonstrated a slow migrating band in the chromatin-
associatedfraction(Fig.2D),indicatingthatphosphorylatedRECQ1
is preferentially associated with chromatin upon IR exposure.
RECQ1 was also phosphorylated in response to ultraviolet light or
the replication inhibitor hydroxyurea (Fig. S1B).
RECQ1 depletion results in a decrease of cellular
growth and proliferation
The proposed roles of RecQ helicases in replication fork
processing suggested that RECQ1 status may influence cellular
growth and proliferation. Since an effect of RECQ1 deficiency on
growth properties had not been previously examined, we
evaluated several biological parameters pertaining to growth and
Figure 1. Nucleolar RECQ1 undergoes re-localization to chromatin in response to IR. Indirect immunofluorescence was performed on HeLa cells
that were either untreated or allowed to recover for 6 h from 10 Gy IR exposure as described in ‘‘Materials and Methods’’. Panel A, Nucleolar
localization of RECQ1 in untreated cells. Cells were co-immunostained with anti-RECQ1 and anti-nucleolin. The merged images show cells stained
with RECQ1 (red) and nucleolin (green), with or without DAPI (blue). Panel B, Relocalization of RECQ1 to chromatin-bound foci following IR damage.
After IR exposure, cells were stained for total RECQ1 (top panel) or in situ detergent extraction-resistant RECQ1 (middle and bottom panel). Merged
images show RECQ1 (red) and DAPI (blue). Co-immunostaining of chromatin-bound RECQ1 and c-H2AX (Panel B, bottom). Merged images show
RECQ1 (red) and c-H2AX (green), with or without DAPI (blue). Panel C, Schematic presentation of the protocol for sequential nuclear fractionation of
lysates from U2OS cells either untreated or following 6 h recovery from 10 Gy IR exposure. Cytoplasmic and nucleoplasmic proteins were extracted
by permeabilization with detergent, and the resulting nuclei were nuclease-digested and extracted with NH2SO4. Proteins of the supernatant (S) and
pellet (P) fractions were resolved on 10% SDS-PAGE, and subsequently analyzed by Western blot for RECQ1, histone H4 (chromatin marker), and lamin
B (nuclear matrix marker). Panel D, Following IR treatment, RECQ1 is enriched in the chromatin fraction (S4).
doi:10.1371/journal.pone.0001297.g001
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intereference. siRNA depletion of RECQ1 during a 48 h time
period led to a decrease of .90% of RECQ1 compared to control
as observed by Western blotting (Fig. 3A). Beginning 48 h after
siRNA treatment, total DNA content was evaluated at 24 h time
intervals as a measure of cell proliferation. The results, shown in
Fig. 3B, demonstrate that RECQ1 depletion by either the
siRNAL1 or siRNAL2 oligonucleotides resulted in a statistically
similar reduction in total DNA content compared to cells treated
with the control siRNA. At day 2, total DNA content was
increased over 3-fold in control siRNA transfected cells whereas
there was statistically no increase in DNA content in the siRNA
RECQ1-depleted cells. At day 3, the control cultures had
increased their DNA content 5-fold. In contrast, the DNA content
of RECQ1-depleted cells increased only 1.5-fold. Measurable
differences in metabolic activity between the control and RECQ1-
depleted cells were detected using the MTT assay (Fig. 3C),
consistent with the observed decrease in cellular DNA content. To
test the mitogenic efficiency of RECQ1-depleted cells, we
evaluated BrdU incorporation as a measure of DNA synthesis.
The results from these experiments, shown in Fig. 3D, demon-
strate that RECQ1-depleted cells are impaired for their ability to
synthesize DNA as compared to control siRNA treated cells.
Taken together, these results suggest that RECQ1 has a regulatory
role in cell proliferation.
ToevaluatetheimportanceofRECQ1forcellgrowth,HeLacells
were transfected with a plasmid encoding shRNA against RECQ1
or a control plasmid. This approach enabled us to assess the effect of
RECQ1 depletion on cell number and colony forming ability.
Efficient depletion of RECQ1 protein was observed in the whole cell
extracts of puromycin resistant cultures that harbor RECQ1 shRNA
plasmid as compared to the control (Fig. 4A). To determine the
proliferative survival of RECQ1-depleted cells, an equivalent
number of puromycin resistant cells were plated and counted
sequentially for 5 days using a Coulter counter. Cells that had been
transfected with plasmid encoding RECQ1 shRNA displayed
reduced cell numbers compared to the control cells on days 3, 4
and 5 (Fig. 4B). Colony forming assay displayed a significant
reduction in both the size and number of colonies when cells were
inhibited for the expression of RECQ1 (Fig. 4C). RECQ1-depleted
HeLa cells reproducibly displayed an increased (.2-fold) percentage
of cells in the G2 phase compared to the control cells (Fig. 4D and
4E), suggesting perturbation of normal cell cycle progression.
Spontaneous and DNA damage-induced apoptosis
of RECQ1-depleted cells
Programmed cell death by the apoptotic pathway is an important
component of the cellular response to stress or DNA damage.
Mutations in genes encoding RecQ helicases and other tumor
Figure 2. Phosphorylation of endogenous RECQ1 in response to IR. Panel A, RECQ1 was immunoprecipitated from whole cell extracts of U2OS cells
that were either untreated or allowed to recover for 6 h from 10 Gy IR exposure. The RECQ1 immunoprecipitate from each cell extract was divided in
half and was either incubated or not with l-phosphatase (500 U) for 1 h at 30uC before elution with SDS sample buffer. The immunoprecipitated
proteins were resolved on 12% SDS-PAGE, transferred to PVDF membranes, and probed for RECQ1. Panel B, IR-induced RECQ1 phosphorylation is
dependent on radiation dose. RECQ1 was immunoprecipitated from either untreated cells or 6 h after treatment of cells with the indicated dose of c-
radiation. Immunoprecipitated proteins were divided in two aliquots which were either treated with l-phosphatase or left untreated. RECQ1 was
detected as described above. Panel C, Time course of RECQ1 phosphorylation in response to IR. U2OS cells were subjected to c-radiation (10 Gy), and
RECQ1 was immunoprecipiated from whole cell extracts prepared at the indicated time points following IR exposure. Panel D, Phosphorylated RECQ1
is preferentially associated with chromatin in IR-treated cells. RECQ1 was immunoprecipitated from the detergent-soluble (S2) and insoluble (S4)
fractions of untreated or IR treated cells, resolved on 12% SDS-PAGE, and detected by Western blot analysis.
doi:10.1371/journal.pone.0001297.g002
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defective in stress-induced apoptosis [29–33]. The negative effect
of RECQ1 depletion on cellular proliferation raised the possibility
that RECQ1 status might affect apoptotic potential. As shown
quantitatively in Fig. 5A, there was no difference observed in
apoptosis as measured by cytoplasmic mono- and oligo-nucleo-
somes between untreated control or RECQ1 siRNA treated cells;
however, RECQ1 depleted cells exposed to 400 mMH 2O2,a
concentration previously shown to induce apoptosis [34], were
compromised in their apoptotic response compared to control
siRNA treated cells which doubled their level of apoptosis after
H2O2 exposure. Similarly, PARP-1 cleavage was also reduced in
RECQ1-depleted cells after H2O2 exposure compared to the
control cells (Fig. 5B). These results suggest that cellular depletion
of RECQ1 does not induce apoptosis; however, RECQ1 plays a
role in the apoptotic response to H2O2-induced stress which
induces oxidized bases, single-stranded DNA breaks, and double-
stranded DNA breaks.
RECQ1 depletion leads to increased sensitivity to
genotoxic stress
The collective evidence suggesting a vital importance of RecQ
helicases in the maintenance of genomic stability led us to
investigate if human RECQ1 might play a unique role in the DNA
damage response. The elevated IR sensitivity and sister chromatid
exchange in RECQL knockout mouse cells [8] suggested a role of
RECQ1 in HR repair. Therefore, we examined the IR sensitivity
of human cells depleted of RECQ1. HeLa cells transfected with
control or RECQ1 siRNA were exposed to increasing doses of IR,
and cellular proliferation was assayed. As shown in Fig 6A,
depletion of RECQ1 in HeLa cells rendered the cells sensitive to
IR as compared to control siRNA treated HeLa cells.
Evidence that RecQ helicases function to preserve genomic
stability at stalled or broken replication forks [2] prompted us to
examine the sensitivity of RECQ1-depleted cells to CPT, an anti-
tumor drug that inhibits the topoisomerase-induced DNA
breakage-reunion reaction [35]. Topoisomerase I-DNA cleavable
complexes are stabilized by a ternary interaction with CPT
resulting in DSBs at stalled replication forks and cell death. Since
CPT-induced double strand breaks at stalled replication forks are
repaired by recombination, we postulated that RECQ1, like BLM
helicase [36], may be important in the cellular resistance to CPT.
As shown in Fig. 6B, RECQ1 depletion resulted in a significantly
greater sensitivity to CPT at all drug concentrations tested (10, 25,
50 nM). Taken together these results indicate that depletion of
RECQ1 compromises the ability of cells to respond and survive
after IR or CPT-mediated genotoxic stress.
Figure 3. RECQ1-depleted cells show reduced cellular proliferation. Panel A, Small interfering RNA inhibition of RECQ1. Whole cell extracts from
HeLa cells that had been transfected with control or RECQ1 siRNA (oligonucleotide L1 or L2) were subjected to Western blotting with RECQ1 or Actin
antibodies (as a loading control). Panel B, Proliferation of control or RECQ1 siRNA treated cells as determined by CyQuant assay at indicated time
points after transfection. Panel C, MTT assay of in vitro proliferation of control or RECQ1-siRNA transfected cells. Panel D, Colorimetric BrdU cell
proliferation ELISA of control or RECQ1 siRNA treated HeLa cells. Results are taken from three independent experiments and proliferation is
represented as the mean6standard deviation (SD).
doi:10.1371/journal.pone.0001297.g003
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phase DNA damage checkpoint
To determine whether DNA damage signaling is compromised
upon RECQ1 depletion, we examined the DNA damage-induced
G2/M checkpoint in RECQ1 siRNA-treated cells. HeLa cells
were transfected with the indicated siRNA and were either mock-
treated or subjected to 3 Gy IR 48 h after transfection. Cells were
harvested 1 h after treatment and analysed by flow cytometry for
histone H3 phosphorylation as a marker for entry into mitosis. As
expected, very few of the control siRNA-treated cells entered
mitosis after 3 Gy of IR (Fig. 7A). Similarly, RECQ1 siRNA
treated cells showed profound reduction of the phospho-H3
positive 4N population, suggesting that RECQ1 is not essential for
establishment of the G2/M checkpoint.
To determine if RECQ1 is required for the maintenance of the
G2/M checkpoint, cells were irradiated (10 Gy) and incubated in
the presence of nocodazole for 16 h to capture cells entering
mitosis. Cells depleted in RECQ1 yielded a significantly higher
mitotic population, as reflected by the higher percentage of
phospho-H3 positive 4N population, compared to the control
siRNA transfected HeLa cells (Fig. 7B). Increased Phospho-H3
staining indicated that RECQ1 depletion compromises cellular
ability to maintain IR-induced G2/M checkpoint. However,
depletion of RECQ1 did not compromise the ability of cells to
down-regulate DNA synthesis upon IR exposure (Fig. 7C),
suggesting that RECQ1 does not play a major role in intra-S
phase checkpoint.
Depletion of RECQ1 leads to spontaneous formation
of c-H2AX foci
RecQ helicases are thought to be involved in the maintenance and
stabilization of replication forks in response to endogenous stress
or exogenous DNA damage [2]. A failure to stabilize forks can
lead to fork collapse and double strand breaks. To examine the
role of RECQ1 in preventing and responding to double strand
breaks, we analyzed c-H2AX foci formation in control or RECQ1
siRNA transfected cells that were either untreated or exposed to
IR (5 Gy). IR exposure resulted in c-H2AX foci formation;
however, in the absence of exogenous DNA damage treatment we
observed a significantly greater percentage of RECQ1-depleted
Figure 4. Reduced cell growth and aberrant cell cycle progression of RECQ1-depleted cells. Panel A, Short hairpin RNA (shRNA)-mediated RECQ1
depletion in HeLa cells. Western blot showing RECQ1 expression in puromycin resistant HeLa cells transfected with either control or RECQ1 shRNA
(#1o r#2). Actin is used as loading control. Proliferation of control or cells transfected with RECQ1-specific shRNA plasmids was determined by
Coulter counting the total number of cells at indicated time points (Panel B) and by colony forming assay (Panel C). Panels D and E, RECQ1 depletion
induces G2/M accumulation. Flow cytometry was used to determine cell cycle distribution of control or RECQ1 shRNA transfected cells (Panel D)o r
RECQ1 siRNA transfected cells (Panel E).
doi:10.1371/journal.pone.0001297.g004
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control cells (Fig. 8A, 8B). This increased level of c-H2AX that
occurred spontaneously in the RECQ1-depleted cells was also
evident by Western blot analysis (Fig. 8C, lane 1 versus lanes 2 and
3 of middle panel).
RECQ1 depletion leads to increased sister chromatid
exchange
The elevated levels of spontaneous c-H2AX foci in RECQ1-
depleted cells may be a consequence of aberrant recombination at
sites of double strand breaks. A phenotype associated with
defective HR is elevated SCE [1]. Metaphase chromosome
preparations from BrdU-labeled RECQ1-siRNA cells or control
siRNA cells were differentially stained for detection of SCEs
(Fig. 9A). RECQ1-depleted cells displayed a 3.4-fold greater
frequency of spontaneous SCEs compared to the control HeLa
cells. The fold increase in SCE in the RECQ1-depeleted cells is
similar to that reported for HeLa cells depleted of BLM protein or
its binding partner BLAP75 [37]. Increased levels of SCE were
also observed in the RECQ1-depleted cells that were exposed to
the DNA cross-linking agent mitomycin C, as previously published
[38], or the topoisomerase inhibitor CPT (Fig. 9B). Importantly,
the elevated SCE and c-H2AX foci suggest that RECQ1 is
involved in the resolution of HR intermediates and its absence
leads to accumulation of DNA damage.
RECQ1 interacts with the strand exchange protein
Rad51
AkeyproteininthestrandexchangereactionofHRisRad51,which
facilitates strand invasion of ssDNA into a homologous duplex. To
evaluate if Rad51 recombinase and RECQ1 helicase are associated
with each other, we performedco-immunoprecipitation experiments
using antibodies directed against either Rad51 or RECQ1 to
immunoprecipitate the target protein and its potential protein
partner from nuclear extracts. The results demonstrate that RECQ1
and Rad51 can be reciprocally immunoprecipitated with each other
(Fig. 10A). RECQ1 immunoprecipitate also contained MSH2/6
and MLH1 (data not shown), previously shown to interact with
RECQ1 [13]. A direct interaction between Rad51 and RECQ1 was
confirmed by ELISA using purified recombinant proteins. Rad51
bound RECQ1 in a protein concentration-dependent manner
(Fig. 10B). In control experiments, a very low OD490 signal was
detected when BSA (0–76 nM) was substituted for RECQ1 or
Rad51 was omitted from the binding incubation (Fig. 10B, 10C).
The specific binding of Rad51 to the RECQ1-coated wells was
Figure 5. Effect of RECQ1 depletion on spontaneous or oxidative
stress induced apoptosis. HeLa cells were siRNA treated for 48 h, and
then incubated in complete medium for 24 h. Cells were either
untreated or incubated with 400 mMH 2O2 for 3 h in serum free
medium, washed, and allowed to recover in complete medium for 21 h.
Panel A, Enrichment of the cytoplasmic histone-associated-DNA
fragments that are indicative of an ongoing apoptosis in cells with
the indicated siRNA oligonucleotides. Samples were analyzed in
duplicates, and data points represent the mean of three independent
experiments; bars denote SD. Panel B, immunoblotting analysis of the
PARP cleavage in control or RECQ1 siRNA treated HeLa cells either
untreated or exposed to 400 mMH 2O2.
doi:10.1371/journal.pone.0001297.g005
Figure 6. RECQ1 depletion sensitizes cells to DNA damage induced by ionizing radiation or camptothecin. siRNA knockdown of RECQ1 in HeLa
cells leads to increased sensitivity to treatment with IR (Panel A) or CPT (Panel B). HeLa cells treated with either RECQ1 siRNA or control siRNA (#C)
were plated in quadruplicate and treated with increasing doses of IR or concentrations of CPT. Total DNA content was measured as an indication of
cell growth. Two independent siRNAs (#L1 and #L2) used to downregulate RECQ1 expression resulted in similar growth phenotype in HeLa cells.
Three independent determinations of cell survival were performed and the mean6SD is presented.
doi:10.1371/journal.pone.0001297.g006
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described [39], and the apparent dissociation constant (Kd)w a s
determined to be 11.962.1 nM. Furthermore, the interaction of
RECQ1 and Rad51 was demonstrated to be DNA independent, as
evidenced by the similar colorimetric signal observed for RECQ1/
Rad51 interaction in the presence of ethidium bromide (EtBr) or
DNaseI (Fig. 10C).
DISCUSSION
Given the genetic linkage of other human RecQ helicases (WRN,
BLM, RECQ4) to diseases characterized by premature aging,
cancer, and chromosomal instability, we investigated the signifi-
cance of human RECQ1 for genome integrity, and more
specifically its role in the DNA damage response. In this work,
we have demonstrated that endogenous human RECQ1 becomes
phosphorylated and re-localizes its sub-nuclear distribution to the
chromatin fraction upon cellular exposure to DNA damage.
Depletion of RECQ1 renders cells sensitive to IR or the
topoisomerase inhibitor CPT, and results in spontaneous c-H2AX
foci and elevated SCE, indicating an accumulation of double strand
breaks. The biological results suggest that RECQ1 either serves to
prevent doublestrand breaksfrom forming ordirectlyhelps torepair
double strand breaks through its interaction with HR repair proteins
such as Rad51. Collectively, these studies provide the first evidence
for a role of human RECQ1 in the response to DNA damage and
chromosomal stability maintenance and point to the vital impor-
tance of RECQ1 in genome homeostasis.
The significant reduction in cell proliferation due to RECQ1
depletion in human cells is different from that observed in mice in
which RECQ1 deficiency had no obvious effect on the growth/
proliferation of mouse embryonic fibroblasts nor the normal
development or postnatal growth of mice [8]. The phenotypes of
complete loss of human RECQ1 are likely to be more severe than
Figure 7. Effect of RECQ1 depletion on G2/M and intra-S-phase DNA damage checkpoints. Panel A, DNA damage-induced mitotic entry delay is
minimally affected by the RECQ1 deficiency. HeLa cells were transfected with the indicated siRNAs and either mock-treated or exposed to 3 Gy of IR
1 h before harvesting. Mitotic cells were detected by PI and phosphohistone H3 staining and analyzed by flow cytometry. Percentages of mitotic cells
and their levels normalized to control (in parentheses) are shown. Panel B, RECQ1 is involved in maintenance of IR-induced G2/M checkpoint. Cells
with either control or RECQ1 siRNA were exposed to 10 Gy of IR. Nocodazole (1 mg/ml) was added to the medium at the time of IR treatment to
capture cells entering mitosis. 16 h later, cells were collected for PI and phospho-histone H3 staining and analyzed by flow cytometry. Panel C, HeLa
cells transfected with control or RECQ1 siRNAs were exposed to 10 Gy of IR and assayed for DNA synthesis 30 min later by [
3H]thymidine
incorporation. The amount of DNA synthesis after irradiation is expressed as a percentage of the level in untreated cells. Error bars indicate SD from
three independent experiments.
doi:10.1371/journal.pone.0001297.g007
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that protocol presumably selects for clones that fail to completely
silence RECQ1. This allows the possibility that RECQ1 is
essential for cell viability in humans, in contrast to the case in mice.
It is conceivable that manifestation of cellular or organismal
phenotypes in Recql-null mice may be masked by other genetic
factors. For example, WRN-null mice do not exhibit any
phenotypes prevalent in WS; however, premature aging pheno-
types are observed in a WRN-null telomerase-knockout mouse
characterized by the presence of critically short telomeres (for
review, see [40]). Furthermore, late generation mTerc-/- WRN -/-
mouse embryonic fibroblasts have an increased load of DNA
damage and replicative senescence, properties similar to that
observed in human WS fibroblasts.
In addition to their growth defects, RECQ1-depleted human cells
display defective maintenance of the G2/M checkpoint following IR
exposure and an aberrant apoptotic response to H2O2-induced
stress. The role of RECQ1 in the apoptotic response may be either
direct or the effect could be secondary, and the reduction in
genotoxic stress-induced apoptosis could be due to the altered cell
cycle distribution or viability of the RECQ1-depleted cells.
Intra-nuclear trafficking of nuclear proteins is an important
aspect of the DNA damage response since DNA repair factors are
known to localize to DNA damage foci. RECQ1 is predominantly
found in the nucleoli of proliferating human cells and re-localizes
to the nucleoplasm in response to IR-induced DNA damage or
replicational stress induced by hydroxyurea. Like RECQ1, WRN
and BLM also re-localize to the nucleoplasm after DNA damage
[41–43]; however, RECQ4 is constitutively present in nuclear foci
irrespective of DNA damage [44], suggesting some differences in
the sub-cellular distribution of human RecQ helicases before and
after DNA damage.
Figure 8. Depletion of RECQ1 leads to spontaneous formation of c-H2AX foci in the absence of exogenous damage. Panel A, Control or RECQ1
siRNA-treated HeLa cells were grown on coverslips, fixed with formaldehyde and co-immunostained with anti- c-H2AX and anti-RECQ1 antibodies.
The merged picture shows cells stained with anti- c-H2AX (green) and anti-RECQ1 (red) as well as DAPI (blue). Normal induction of c-H2AX foci is
shown upon IR (5 Gy) exposure in RECQ1 depleted cells. Panel B, Quantitative assessment of c-H2AX foci in control or RECQ1-depleted cells that have
been either untreated or exposed to IR, as described in Panel A. Images of at least 100 cells were captured and used for quantitative analyses of c-
H2AX foci. To avoid bias in the selection of cells, DAPI stained nuclei were randomly selected for c-H2AX staining. Panel C, HeLa cells were treated
with control or RECQ1 siRNA. Following IR exposure or not, cell lysates were immunoblotted with anti-RECQ1, anti- c-H2AX, or anti-actin antibodies.
doi:10.1371/journal.pone.0001297.g008
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subset of RECQ1 molecules becomes resistant to detergent
extraction after IR exposure, probably due to their tighter
association with sites of damage in chromatin. Endogenous RECQ1
isphosphorylatedinresponsetoDNAdamageorreplicationalstress,
and preferentially associates with chromatin. A number of predicted
phosphorylation sites for various stress-activated kinases exist in
RECQ1. Our unpublished results indicate that RECQ1 is
phosphorylated after DNA damage in AT mutated cells, suggesting
that ATM is not the major candidate kinase. In vitro phosphorylation
of RECQ1 by Protein Kinase C or Casein Kinase II modulates its
catalytic activities (data not shown). RECQ1 and its protein partners
may be localized to sites of DNA damage where RECQ1 utilizes its
catalytic activities to process genomic DNA structures as a
component of the DNA damage response.
In agreement with this, RECQ1 deficiency in both mouse [8] and
human cells resulted in an increased sensitivity to IR or CPT which
introduce strand breaks that can be converted to double strand
breaks during replication. Spontaneously elevated c-H2AX foci and
SCEs observed in RECQ1-depleted cells (this study and reference
[38]) may be due to unsuccessful attempts to ‘repair’ damaged
replication forks by HRat doublestrand breaks. Thus, RECQ1 may
have a direct role in repairing double strand breaks. Alternatively,
RECQ1 may act to prevent double strand breaks from occurring in
the first place. The latter explanation would be consistent with our
observation that only a minority of RECQ1 co-localizes with
c2H2AX foci. The sensitivity of RECQ1 deficient cells to other
DNA damaging agents remains unexplored and RECQ1 might also
participate in other DNA repair pathways.
Strong candidates for RECQ1 protein interactors that serve to
suppress cross-over of sister chromatids are recombination
proteins, mismatch repair factors that regulate genetic recombi-
nation [13], and Type IA topoisomerases that have been
implicated genetically and biochemically to collaborate with RecQ
helicases to preserve chromosomal integrity [2]. It is conceivable
that Rad51 may act to regulate RECQ1 helicase activity on HR
intermediates (D-loop, Holliday Junction) that RECQ1 has the
ability to unwind [10] since Rad51 plays a critical role in the
strand invasion step of HR repair of strand breaks. However, we
did not detect an effect of Rad51, inhibitory or stimulatory, on
RECQ1 catalyzed unwinding of a variety of oligonucleotide-based
DNA substrates including forked duplex, D-loop, or synthetic
Holliday Junction (data not shown). RECQ1 may utilize its motor
ATPase function to displace Rad51 from inappropriate strand
invasion intermediates that are either homeologous or occur in an
untimely manner. A similar function was proposed for the yeast
Srs2 helicase which physically binds to Rad51 [45] and displaces
the strand exchange protein from DNA [45,46].
Our observation that human RECQ1 directly interacts with
Rad51 is consistent with other reports that RecQ helicases (BLM,
Sgs1 [47]) function in DNA repair through HR by their physical
interactions with Rad51. It was proposed that the physical
interaction between BLM and Rad51 serves to recruit BLM to
sites of recombinational repair and possibly load BLM onto
Holliday Junctions in a particular orientation that would then
dictate the direction of junction translocation. The spontaneously
elevated nuclear Rad51 foci observed in BS cells [47] and Recql
2/
2 cells [8] may represent accumulation of unresolved recombina-
tion intermediates or a greater load of endogenous DNA damage
in the absence of the RecQ helicase. Our earlier demonstration
that RECQ1 interacts physically and functionally with mismatch
repair proteins [13] is likely to be important in the mechanisms
whereby RECQ1 regulates genetic recombination. MSH2/6
proteins may interact with RECQ1 to unwind recombination
intermediates that contain mismatches, as proposed for the
mechanism of Sgs1 to prevent homeologous recombination [48].
It was suggested that the fission yeast Rqh1 helicase functions
after Rad51 focus formation during DNA repair through its
interaction with Topoisomerase III in G2 [49]; however, Rqh1
and other RecQ helicases may have early and late roles in
homologous recombination [50]. Human RECQ1 was reported to
physically interact with Topo IIIa [14], and Rad51 focus
formation after DNA damage is not dependent on RECQ1 in
mouse cells [8]. It is likely that RECQ1 utilizes its catalytic helicase
and strand annealing activities to facilitate the resolution of HR
repair intermediates with other proteins intimately involved in this
process. The observed elevated SCE after CPT-induced DNA
damage is consistent with this proposal.
BLM has been proposed to suppress SCEs by its concerted
action with Top3a [51]; however, RECQ1, WRN, and RECQ5b
were not able to substitute for BLM in Top3a mediated double
Holliday Junction dissolution on model DNA substrates in vitro
[52]. RECQ1
2/2 BLM
2/2 or RECQ5
2/2 BLM
2/2 DT40 cells
displayed a growth defect, and RECQ5
2/2 BLM
2/2 cells had a
higher SCE frequency compared with BLM
2/2 cells [6]. An
independent role of RECQ5 in sister chromatid exchange
suppression was demonstrated in embryonic stem cells or
differentiated fibroblasts from RECQ5-knockout mice [7]. Primary
embryonic fibroblasts from the RECQ1 knockout mouse display
spontaneously elevated SCEs and chromosomal aberrations [8],
suggesting that RecQ helicases participate in non-redundant
pathways to suppress cross-overs during mitosis.
Although a genetic disorder has not yet been linked to a
mutation in RECQ1, recent analyses of RECQ1 single nucleotide
polymorphisms (SNPs) have identified an association of RECQ1
with a reduced survival of pancreatic cancer patients [53,54].
RECQ1 SNPs displayed significant genetic interaction with SNPs
Figure 9. Elevated sister chromatid exchanges in RECQ1-depleted
human cells. Panel A, SCEs were assayed in BrdU labeled, giemsa-
stained chromosome spreads from control or RECQ1 siRNA treated
HeLa cells. A representative spread is shown for spontaneous SCEs in
control and RECQ1-depleted cells. Panel B, Quantitative representation
of the number of SCEs per metaphase, either spontaneous or induced
by CPT or MMC in cells treated with either control or RECQ1 siRNA. A
minimum of 25 metaphases were counted for each cell type and
treatment.
doi:10.1371/journal.pone.0001297.g009
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XRCC2 and XRCC3. A role of RECQ1 in HR is further
suggested by the observation that SNPs in RECQ1 affect the
response to the anti-cancer drug gemcitabine induced radio-
sensitization that selectively requires functional HR [53,54]. The
chromosomal instability arising from RECQ1 deficiency may
contribute to a cancer predisposition. RECQ1 is differentially up-
regulated in transformed cells or cells that are actively proliferating
[5]. We propose that RECQ1 confers genomic integrity in
transformed or actively proliferating cells.
The human RECQ1 gene is localized to chromosome 12p11-12
[3,55], a location of instability in testicular germ-cell tumors [56].
RECQ1 expression in mouse is highest in the testis [8]. The
purification of a RECQ1 ribonucleoprotein complex from rat
testis with testis-specific small non-coding piRNAs involved in
gene silencing, cell growth, and development [57] raises the
question of what is the precise mechanism whereby RECQ1 and
its associated piRNA complex regulates the germ-line. The
mechanistic similarities between piRNA synthesis and DNA
replication [58] suggest that RECQ1 and its associated DNA
replication/repair proteins (RPA, EXO-1, MSH2/6) are involved
in piRNA biogenesis. This is an unexpected and potentially
exciting role for RECQ1 protein in the metabolism of regulatory
small RNAs important for development and mechanisms of
inheritance. Presently, it can only be speculated if the piRNA
complex regulates the genome at the level of DNA or histones, or
at a posttranscriptional level. Interestingly, QDE-3, the RECQ1
homolog in Neurospora crassa, has also been implicated in gene
silencing [59]. The qde-3 mutant was found to be hypersensitive to
a variety of DNA mutagens and exhibit increased mutability and
extensive chromosomal deletions [60–62], implicating a broader
role of the Neurospora RECQ1 homolog in the DNA damage
response and chromosomal stability. Our cellular studies implicate
a unique and important role of human RECQ1 in genome
homeostasis as well. Further work is required to understand
RECQ1-piRNA genome defense association. Clearly, RECQ1
has become the latest member of the RecQ helicase family with
important biological functions through its involvement in the DNA
damage response and fundamental processes of chromosomal
nucleic acid metabolism.
Figure 10. RECQ1 interacts with Rad51. Panel A, Co-immunoprecipitation of RECQ1 and Rad51 from HeLa nuclear extracts. Rad51 was detected in
RECQ1 immunoprecipitates (lane 3). RECQ1 was immmunoprecipitated with Rad51 from nuclear extracts as detected by Western blot (lane 5). Lanes
2 and 4 represent immunoprecipitate from control rabbit and mouse IgG, respectively. Input (lane 1) represent 10% of the total protein used for
immunoprecipitation. Panels B and C, ELISA for RECQ1-Rad51 interaction. Either BSA or purified recombinant human RECQ1 (14 nM) was coated onto
microtiter plates. Following blocking with 3% BSA, appropriate wells were incubated with the indicated concentrations of purified recombinant
human Rad51 (0–76 nM, Panel B or 76 nM, Panel C) for 1 h at 30uC. In Panel C as indicated, DNaseI (100 U/ml) or ethidium bromide (EtBr) (50 mg/ml)
was included in the incubation with Rad51 in the binding step in the corresponding wells to test for DNA-mediated protein interaction. Following
washing, RECQ1 bound Rad51 was detected by ELISA using rabbit polyclonal antibody against Rad51. The values represent the mean of three
independent experiments performed in duplicate with SD indicated by error bars.
doi:10.1371/journal.pone.0001297.g010
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